Product Name | MF | CAS | Details |
---|
3-Pyridinesulfonyl chloride | C5H4ClNO2S | 16133-25-8 | Details |
Ethyl 7-chloro-8-cyano-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate | C16H12ClFN2O3 | 117528-64-0 | Details |
(+)-(3R,4R)-3,4-Dimethyl-4-(3-Hydroxyphenyl)Piperidine | C13H19NO | 119193-19-0 | Details |
Omarigliptin | C17H20F2N4O3S | 1226781-44-7 | Details |
2-(Methylsulfonyl)-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole benzenesulfonate | C12H15N3O5S2 | 1280210-80-1 | Details |
Alvimopan | C25H32N2O4 | 156053-89-3 | Details |
Micafungin FR-179642 | C35H52N8O20S | 168110-44-9 | Details |
(S)-2-(((3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoic acid methyl ester hydrochloride | C24H31NO3.HCl | 170098-28-9 | Details |
(-)-(4aS,7aS)-8-Cyano-1-cyclopropyl-6-fluoro-4-oxo-7-(perhydropyrrolo[3,4-b]-1,4-oxazin-6-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride | C20H19FN4O4 | 209342-40-5 | Details |
1H-Pyrazolo[3,4-b]pyridine-3-carboximidamide,1-[(2-fluorophenyl)methyl]-, monohydrochloride | C14H13ClFN5 | 256499-19-1 | Details |
Silodosin intermediate | Details |
Shakubi triflusartan intermediate | Details |
1S,6S-2-oxa-5,8-diazabicyclo[4.3.0.]decane | Details |
4-Chloro-3-(trifluoromethyl)phenyl isocyanate | C8H3ClF3NO | 327-78-6 | Details |
2(S)-[2-Oxo-4(R)-propylpyrrolidin-1-yl]butyramide | C11H20N2O2 | 357336-20-0 | Details |
Isoxazole, 5-methyl-3,4-diphenyl- | C16H13NO | 37928-17-9 | Details |
2-[1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidine-4,5,6-triamine | C17H15FN8 | 428854-24-4 | Details |
[(E)-phenyldiazenyl]propanedinitrile | C9H6N4 | 6017-21-6 | Details |
[4,6-Diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]methylcarbamic acid methyl ester | C20H19FN8O2 | 625115-55-1 | Details |
2(3H)-Furanone,dihydro-4-propyl-,(R)- | C7H12O2 | 63095-51-2 | Details |
CPo3604-01 | C16H19F2NO4 | 951127-25-6 | Details |
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate | C11H13F3O5S | 160969-03-9 | Details |
2,6-Dibromo-4-methylpyridine | C6H5Br2N | 73112-16-0 | Details |
2-chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile | C11H6ClFN2 | Details |
Ethyl 3-(2-pyridylamino)propionate | C10H14N2O2 | Details |
5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile | C11H7FN2 | 1240948-77-9 | Details |
Vonoprazan fumarate | C21H20FN3O6S | 1260141-27-2 | Details |
TAK-438 impurity | Details |
Acemetacin Impurity F | Details |
5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde | C11H8FNO | 881674-56-2 | Details |
Dabigatran etexilate | C34H41N7O5 | 211915-06-9 | Details |
3-[(3-AMINO-4-METHYLAMINO-BENZOYL)-PYRIDIN-2-YL-AMINO]-PROPIONIC ACID ETHYL ESTER | C18H22N4O3 | 212322-56-0 | Details |
N-(4-CYANO-PHENYL)-GLYCINE | C9H8N2O2 | 42288-26-6 | Details |
3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester | C27H26N6O3 | 211915-84-3 | Details |
pramipexole dihydrochloride | C10H19Cl2N3S | 104632-25-9 | Details |
OLANZAPINE N-OXIDE | C17H20N4OS | 174794-02-6 | Details |
TAK-438 intermediate | Details |
Azilsartan iMpurity A | C25H23N3O4 | 147404-76-0 | Details |
Olanzapine Impurity C | C18H22Cl2N4S | 719300-59-1 | Details |
Rivaroxaban iMpurity | C15H17N3O5 | 1616563-62-2 | Details |
Sitagliptin phosphate monohydrate | C16H18F6N5O5P | 654671-77-9 | Details |
Gamithromycin | C40H76N2O12 | 145435-72-9 | Details |
3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide | C16H14N2O3S | 2304623-36-5 | Details |
Asp(OtBu)-OtBu · HCl | Details |
Silodosin | C25H32F3N3O4 | 160970-54-7 | Details |
Sorafenib IMpurity | C8H10N2O2 | 1256817-30-7 | Details |
Topiroxostat Impurity | C13H9N5O2 | 2044702-36-3 | Details |
5-[2-Ethoxy-5-[(4-Methyl-4-oxido-1-piperazinyl)sulfonyl]phenyl]-1,6-dihydro-1-Methyl-3-(2-Methylpropyl)-7H-pyrazolo[4,3-d]pyriMidin-7-one | C23H32N6O4S | 1391053-95-4 | Details |
Ticagrelor Impurity N | C23H29FN6O4S | 1643378-47-5 | Details |
Topiroxostat | C13H8N6 | 577778-58-6 | Details |
VALNEMULIN HYDROCHLORIDE | C31H53ClN2O5S | 133868-46-9 | Details |
Azilsartan | C25H20N4O5 | 147403-03-0 | Details |
1-(2-Chloro-4-(4-chlorophenyl)butyl)-1H-imidazole | C13H14Cl2N2 | Details |
PARECOXIB SODIUM | C19H19N2NaO4S | 198470-85-8 | Details |
Tulathromycin A | C41H79N3O12 | 217500-96-4 | Details |
Tulamycin | Details |
Topiroxostat intermediate | C12H14N4O3 | 1207715-20-5 | Details |
1-[3-(Benzoyloxy)propyl]-2,3-dihydro-5-(2-nitropropyl)-1H-indole-7-carbonitrile | C22H23N3O4 | 350797-56-7 | Details |
2-CYANO-4-PYRIDINE CARBOXYLIC ACID METHYL ESTER | C8H6N2O2 | 94413-64-6 | Details |
5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate | C26H31N3O8 | 239463-85-5 | Details |
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride | C27H30ClN7O3 | 211914-50-0 | Details |
GREASE FOR VACUUM LINES | Details |
Sitagliptin Phosphate Impurity | Details |
5-(difluoromethoxy)-2-(((3,4- dimethoxypyridin-2- yl)methyl)sulfonyl)-1Hbenzo[ d]imidazole | C16H15F2N3O5S | Details |
5-(difluoromethoxy)-2-(((3,4- dimethoxypyridin-2-yl)methyl)thio)- 1H-benzo[d]imidazole | C16H15F2N3O3S | Details |
Silodosin intermediate | Details |
Product Total: Product Page: | ||||
1 |